Abstract:Background Anti-tumor necrosis factor alpha (TNF- α ) therapy has made a significant impact on treating psoriasis. Despite these agents being designed to block TNF- α activity, their mechanism of action in the remission of psoriasis is still not fully understood at the molecular level. Results To better understand the molecular mechanisms of Anti-TNF- α therapy, we analysed the global gene expression profile (using mRNA microarray) in peripheral blood mononuclear cells (PBMCs) that were collected from 6 psoriasis patients before and 12 weeks after the treatment of etanercept. First, we identified 176 differentially expressed genes (DEGs) before and after treatment by using paired t-test. Then, we constructed the gene co-expression modules by weighted correlation network analysis (WGCNA), and 22 co-expression modules were found to be significantly correlated with treatment response. Of these 176 DEGs, 79 DEGs (M_DEGs) were the members of these 22 co-expression modules. Of the 287 GO functional processes and pathways that were enriched for these 79 M_DEGs, we identified 30 pathways whose overall gene expression activities were significantly correlated with treatment response. Of the original 176 DEGs, 19 (GO_DEGs) were found to be the members of these 30 pathways, whose expression profiles showed clear discrimination before and after treatment. As expected, of the biological processes and functionalities implicated by these 30 treatment response-related pathways, the inflammation and immune response was the top pathway in response to etanercept treatment, and some known TNF- α related pathways, such as molting cycle process, hair cycle process, skin epidermis development, regulation of hair follicle development, were implicated. Furthermore, additional novel pathways were also suggested, such as heparan sulfate proteoglycan metabolic process, vascular endothelial growth factor production, whose transcriptional regulation may mediate the response to etanercept treatment. Conclusion Through global gene expression analysis in PBMC of psoriasis patient and subsequent co-expression module based pathway analyses, we have identified a group of functionally coherent and differentially expressed genes (DEGs) and related pathways, which has not only provided new biological insight about the molecular mechanism of anti-TNF- α treatment, but also identified several genes whose expression profiles can be used as potential biomarkers for anti-TNF- α treatment response in psoriasis.

The Expression of Chemokine Receptors on Neutrophils in Patients with Psoriasis Vulgaris

Expression of CXCR3 Mrna in Lesions and Peripheral Blood Mononuclear Cell(pbmc)of Patients with Psoriasis Vulgaris

Increased Endocytic Activity in Monocyte-Derived Dendritic Cells in Patients with Psoriasis Vulgaris

Anti-TNF- Αtreatment-Related Pathways and Biomarkers Revealed by Transcriptome Analysis in Chinese Psoriasis Patients

T-lymphocyte Chemotaxis to IL-8 in Patients with Psoriasis in Vitro.

Increased serum level of chemokine CCL27 in patients with psoriasis vulgaris,and its clinical relevance

Expression of CD147,cyclophilin A and cyclophilin B in patients with psoriasis

Advances in the Research of CXCL16 and Psoriasis

Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and Pruritus

T-lymphocyte Chemotaxis to IL-8 in vitro in Patients with Psoriasis

Effect of pharmacological intervention on MIP-1α, MIP-1β and MCP-1 expression in patients with psoriasis vulgaris

Expressions of CK20, S100A7 and Substance P in Different Stages of Psoriatic Lesions and Their Relationship.

Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor

Enhanced Migratory Ability of Neutrophils Toward Epidermis Contributes to the Development of Psoriasis via Crosstalk With Keratinocytes by Releasing IL-17A

Identification of the Relation Between G Protein-coupled Receptors with Human Psoriasis using cDNA Microarray Analysis

Expression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein- 1 in Patients with Psoriasis

Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF.

Expression of RNATES,MCP-1 in serum and synovial fluid in patients with rheumatoid arthritis and its clinical significance

Study on Inflammatory Factors Secreted by Neutrophils in Patients with Psoriasis Vulgaris

Expression and secretion of calcitonin gene related peptide in psoriatic plaque lesions

ARG1 and CXCL2 are potential biomarkers target for psoriasis patients